Post-market surveillance requirements for medical devices in China involve monitoring safety, performance, and adverse event reporting. Manufacturers must establish a quality management system, collect and evaluate clinical data, report incidents to the National Medical Products Administration (NMPA), and comply with the Medical Device Adverse Event Monitoring and Re-evaluation System to ensure patient safety and continuous product improvement.
